Introduction
============

Sulfate respiration is an anaerobic process carried out by a phylogenetically diverse group of organisms including both Bacteria and Archaea. This process is a major contributor to the global cycling of sulfur and carbon in anaerobic habitats, and has very important environmental and economical impacts (Muyzer and Stams, [@B29]; Barton and Fauque, [@B1]). Sulfate reducing prokaryotes (SRP) are found ubiquitously in anaerobic environments, and are particularly abundant in marine habitats due to the high concentration of sulfate in sea water. As a group SRP are physiologically versatile and capable of metabolizing a wide variety of substrates, and they can also grow syntrophically with other organisms in the absence of sulfate (Stams and Plugge, [@B41]; Plugge et al., [@B34]). Despite its fundamental importance, the mechanism of energy conservation in sulfate respiration remains to be fully elucidated. For many years it was thought that quinones did not play a role in the process, despite their known presence in SRP, and intracellular hydrogen cycling was proposed to account for proton motive force generation. Nowadays, hydrogen cycling is considered as only one of the possible pathways for energy conservation, operating in some, but not all SRP (Keller and Wall, [@B18]; Pereira et al., [@B32]). Sulfate reduction is an intracellular process requiring active transport of sulfate, and its activation by reaction with ATP to form adenosine 5′-phosphosulfate (APS). The two terminal reductases, APS reductase (AprAB) and dissimilatory sulfite reductase (DsrAB), are soluble and thus not directly involved in membrane-linked electron transport. One of the key questions remaining about sulfate reduction is the identification of the electron donors to AprAB and DsrAB. The involvement of membrane proteins in the process was first described by Mander et al. ([@B23]) and Pires et al. ([@B33]) through the identification of the DsrMKJOP (initially named Hme) and QmoABC complexes. These two complexes are found both in SRP (Pereira, [@B31]) and in many anoxygenic phototrophic and chemotrophic sulfur-oxidizing bacteria (SOB; Frigaard and Dahl, [@B8]), indicating a dedicated role in sulfur metabolism. Furthermore, the two complexes are conserved in the genomes of SRP described to date, with very few exceptions: the archeon *Caldivirga maquilingensis* lacks the *qmoABC* genes and in some Gram-positive bacteria the *qmoC* gene is absent; in both cases also a simpler version of the DsrMKJOP complex occurs, since only the *dsrMK* genes are present (Junier et al., [@B16]; Pereira et al., [@B32]). The QmoABC and DsrMKJOP complexes share an interesting characteristic in that they both contain subunits that are related to heterodisulfide reductases (Hdr) of methanogens (Thauer et al., [@B43]), and subunits known to interact with quinones. In several organisms, the *qmoABC* genes cluster with the *aprAB* genes, and the *dsrMKJOP* genes cluster with *dsrAB*, strongly suggesting an involvement of QmoABC in the electron transfer pathway to AprAB and DsrMKJOP in the electron transfer pathway to DsrAB.

The QmoABC complex has one membrane (QmoC) and two cytoplasmic subunits (QmoAB), and the two QmoC hemes *b* are reduced by quinols, indicating that the Qmo complex participates in electron flow between the quinone pool and the cytoplasm, in a process that may result in energy conservation (Pires et al., [@B33]). In *Desulfovibrio vulgaris* Hildenborough a deletion mutant of the *qmoABC* genes could not grow with sulfate as electron acceptor, but grew normally with sulfite or thiosulfate, providing conclusive evidence that QmoABC is required for reduction of sulfate (Zane et al., [@B45]). Also, in the green sulfur-oxidizer *Chlorobium tepidum* the Qmo complex was shown to be involved in oxidation of sulfite as an intermediary in the sulfur oxidation pathway (Chan et al., [@B3]; Rodriguez et al., [@B35]). These results show that the Qmo complex is involved in electron flow between the menaquinone pool and APS reduction or oxidation by AprAB. However, direct electron transfer between the isolated *Desulfovibrio desulfuricans* ATCC 27774 Qmo complex and AprAB could not be detected, which could indicate that additional proteins are involved in the pathway (Pires et al., [@B33]). In this work we report protein--protein interaction studies that show that there is a direct interaction between QmoABC and AprAB, and that the interaction involves the QmoA subunit. The mechanism of AprAB reduction is further discussed.

Materials and Methods
=====================

Protein purification
--------------------

Cells of *D. desulfuricans* ATCC 27774 were grown according to Liu and Peck ([@B22]). The cells were broken and centrifuged and the membrane fraction was used to purify the QmoABC complex in *n*-Dodecyl-β-[d]{.smallcaps}-maltoside (DDM), as previously described by Pires et al. ([@B33]), following its characteristic UV--Visible absorption spectrum. The purification of Qmo was carried out both in aerobic and anaerobic conditions. AprAB was purified from the soluble fraction in anaerobic conditions following the catalytic activity of sulfite oxidation (Fritz et al., [@B10],[@B11]). Anaerobic purifications were carried out inside a Coy anaerobic chamber (95% N~2~, 5% H~2~) using an AKTA^™^ Prime plus^™^ system. The soluble fraction from *D. desulfuricans* was ultracentrifuged at 140,000 × *g* for 2 h, and then applied to a Q-Sepharose FF column equilibrated with 50 mM Tris--HCl (pH 7.6) buffer with 10% glycerol (v/v; buffer A). A stepwise gradient of increasing NaCl concentration was performed and fractions were separated according to UV--Visible spectra. The fractions containing highest AprAB activity, which eluted between 180 and 200 mM NaCl, were pooled. After concentration and lowering of ionic strength, this sample was loaded on a Q-Sepharose HP column equilibrated with buffer A. Again, a stepwise gradient of increasing NaCl concentration was performed. The fractions were separated according to the UV--Visible spectra and activity. The pool of fractions with higher activity was diluted in buffer A and applied in a second Q-Sepharose HP column equilibrated with 10 mM potassium phosphate buffer (pH 7) containing 10% glycerol (v/v; Buffer B). A stepwise gradient of increasing NaCl concentration was performed, and fractions containing purified AprAB eluted at 150 mM NaCl. The purified enzyme had a sulfite oxidation activity of 3.3 μmol min^−1^ mg^−1^ and displayed the characteristic two subunits on an SDS-PAGE gel.

APS reductase activity
----------------------

The AprAB activity was determined as formation of APS in 50 mM Tris--HCl (pH 7.6), 2 mM Na~2~SO~3~, 2 mM AMP, 1 mM K~3~Fe(CN)~6~, at room temperature (Fritz et al., [@B9], [@B10]), or by APS reduction in 80 mM potassium phosphate (pH 7), 30 μM APS, and 0.75 mM methyl viologen as reductant (Fritz et al., [@B10]). Methyl viologen was reduced with 0.2 g of metallic zinc granules in the same buffer.

Co-immunoprecipitation
----------------------

Antibodies for QmoABC complex and AprAB from *D. desulfuricans* were produced from the purified proteins by Davids Biotechnology (Regensburg, Germany) and used for Co-immunoprecipitation (Co-IP) experiments with the Thermo Scientific Pierce^®^ Co-IP kit, following the kit instructions. The anti-Qmo antibody did not cross-react with AprAB, and the anti-Apr antibody did not cross-react with QmoABC. Two approaches were used to investigate protein--protein interaction, one based on Anti-QmoABC antibodies and the other based on Anti-AprAB antibodies. In the first case, 500 μg of Anti-QmoABC antibody were immobilized in the AminoLink^®^ Plus Coupling Resin in a small column, and 1 μM of Qmo in the kit Lysis/Wash buffer was added and incubated for 1 h at 4°C. After one washing step with Lysis/Wash buffer 1 μM of AprAB in the same buffer was loaded in the column and incubated for 2 h at 4°C. After five washing steps, the co-IP products were eluted with the kit Elution buffer. The protocol was repeated with 500 μg of Anti-AprAB antibody, 1 μM of AprAB, and 1 μM of QmoABC in the same buffer. Control experiments were run in parallel with no antibody bound to the control resin. The eluates (∼100 μg) were separated in SDS-PAGE gels \[12% acrylamide, (v/v)\], and transferred to polyvinylidene difluoride (PVDF) membranes (Transfer buffer: 48 mM Tris--HCl pH 9.2 and 39 mM Glycine) using a Mini Trans-Blot^®^ electrophoretic transfer cell (Bio-Rad) during 40 min at 4°C, 100 V, and 350 mA. The membranes were blocked with blocking buffer \[20 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20 (v/v), and 5% non-fat milk (w/v)\], overnight at room temperature. After two washing steps with TBST \[20 mM Tris--HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20 (v/v)\] anti-QmoABC antibody at 1:200 dilution in TBST or anti-AprAB antibody at 1:1,000 dilution in TBST were incubated with the membranes for 1 h, followed by two washing steps with TBST, and incubation with anti-rabbit IgG antibody (Sigma-Aldrich^®^) at 1:15,000 dilution in TBST for 45 min. After three washing steps with TBS, protein detection was performed with Alkaline Phosphatase Buffer (100 mM Tris--HCl pH 9.5, 100 mM NaCl, and 5 mM MgCl~2~), and NBT (nitro-blue tetrazolium chloride)/BCIP (5-bromo-4-chloro-3-indolyl phosphate).

Surface plasmon resonance
-------------------------

The surface plasmon resonance (SPR) experiments were performed at 25°C on a BIAcore 2,000 instrument (Biacore Inc., GE HealthCare). The proteins samples were exchanged to the buffer used as running buffer for the SPR experiments \[10 mM HEPES pH 7.4 + 150 mM NaCl + 3 mM EDTA + 0.01% DDM (w/v)\], using a HiTrap^™^ Desalting column (Amersham Biosciences). AprAB was immobilized in a CM5 sensor chip (GE^®^ Healthcare) by standard NHS/EDC amine coupling resulting in an immobilization level of 1,000 RU. Flow cell 1 was similarly treated with buffer in the absence of AprAB (control cell). Interaction experiments with QmoABC were performed with duplicate injections of 3.9, 7.8, 15.6, 31.25, 62.5 nM of QmoABC at a flow rate of 15 μl/min. After the end of each injection dissociation was performed with running buffer for 10 min, after which all of the protein completely dissociated from the surface (as indicated by a return to baseline level of the sensorgram) and thus no further regeneration was required. The sensorgrams were processed using the double referencing method to eliminate the non-specific binding from background contribution and the buffer artifacts were removed by subtracting signals from the reference flow cell and from buffer blank injections. The BIA evaluation 3.2 RC1 analysis software was used to determine *k*~a~ and *k*~d~ from the processed data sets by globally fitting to a 1:1 biomolecular binding model with drifting baseline. The *K*~D~ was calculated from the quotient *k*~d~/*k*~a~.

For the competition experiments, 62.5 nM of QmoABC was incubated with 62.5 or 125 nM AprAB and injected in the chip surface at the same flow rate as before.

Cross-linking far-western blot
------------------------------

Ten microgram of pure QmoABC were separated in a 12% SDS-PAGE gel and blotted to a PVDF membrane. After overnight blocking, the membrane was incubated with AprAB (1 μM) for 1 h in 20 mM Tris--HCl pH 7.6, 10% Glycerol (v/v), at room temperature. The membrane was washed once with bidistilled water (bDW) and incubated with 32 mM *N*-ethyl-*N*′-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC; Sigma-Aldrich^®^) in bDW for 1 h at room temperature (Sato et al., [@B37]). After three washing steps with bDW, Western Blot against Anti-AprAB was performed. As positive control we used AprAB and as negative control QmoABC that was not incubated with AprAB.

*D. vulgaris* Hildenborough strains and growth conditions
---------------------------------------------------------

A mutant strain lacking the *qmoA* gene was produced by double homologous recombination in *D. vulgaris* Hildenborough -- IPAR02 -- according to Keller et al. ([@B19]), with the exception that following electroporation the cells were recovered and plated in MOYLS3 (lactate 30 mM/sulfite 15 mM) and the electroporation parameters were 1,500 V, 250 Ω, and 25 μF. The pMOIP02 plasmid for the *qmoA* deletion was obtained by sequence ligation independent cloning (SLIC; Li and Elledge, [@B21]). Three segments were amplified by PCR with Herculase polymerase II (Stratagene^®^): 942 bp upstream of *qmoA* (QmoA Up Fw P1-GCCTTTTGCTGGCCTTTTGCTCACATAAGAGCGCGGTTCTGAAATCATGC and QmoA Up Rev P2-CCTGCGTGCAATCCATCTTGTTCAATCATCCTTGGTATCCTCCCTACGTGT), 932 bp downstream of *qmoA* (QmoA Dwn Fw P3-CCTTCTATCGCCTTCTTGACGAGTTCTTCTAGACCATAATGGCCAGCAGAATTGG and QmoA Dwn Rev P4-CGAGGCATTTCTGTCCTGGCTGGAGTGACGTGTTCAGGATGAAGGCA), and the kanamycin resistance gene from pSC27 (Keller et al., [@B19]; Kan aa2 Fw-ATTGAACAAGATGGATTGCACGCAGG and Kan aa264 Rev-GAAGAACTCGTCAAGAAGGCGATAGAAGG), and then added into pMO719 background via SLIC. Products from the amplifications were transformed into *E. coli* α-select Silver Efficiency (Bioline^®^) and successful transformants were isolated on LC medium (Zane et al., [@B45]). Correct isolates were identified by the expected PCR amplicons from the plasmids constructs and also by sequencing performed at the DNA Core Facility at the University of Missouri, USA. The pMOIP02 produced was electroporated into *D. vulgaris* according to Keller et al. ([@B19]), Zane et al. ([@B45]), from which strain IPAR02 was obtained, by selecting with MOYLS3 medium containing 400 μg/ml of geneticin. The deletion of *qmoA* was confirmed by Southern blot. The IPAR02 mutant strain grows in lactate/sulfite as described previously for the mutant lacking *qmoABC* (Zane et al., [@B45]) and is kanamycin resistant.

A complementation plasmid pMOIP05 was produced also by SLIC encoding *qmoA* with a Strep-TEV-FLAG (STF) tag. To create this vector two segments were amplified by PCR: the *qmoA* gene (QmoA Exp Vctr P1 Fw-AGGTTGGGAAGCCCTGCAATGCAGTCCCAGGAGGTACCATATGTCGAACTCCATACTCGTCGTCG and QmoA Exp Vctr P2 Rev-AATTTTTTCGAACTGCGGGTGGCTCCACCTCCCTCTCACCGTTTGAATCGC) and the STF-tag gene from pSLIC-DVU0171-STF-Kan-Tag (Chhabra et al., [@B5]; STF-Tag Fw-TGGAGCCACCCGCAGTTCGAAAAAATT and STF-Tag Rev-GATCGTGATC CCCTGCGCCATCAGATCCTTGCTACTTGTCATCGTCATCCTTGTAGTCGATGTCA); and then added into pMO9075 background via SLIC. The amplifications products were transformed into *E. coli* α-select Silver Efficiency (Bioline^®^), and cells were plated on spectinomycin (100 μg/ml)-containing agar plates. The correct plasmid construct was screened by colony PCR and later confirmed by sequencing at the DNA Core Facility at the University of Missouri, USA.

The pMOIP05 was successfully introduced in IPAR02 by electroporation (Keller et al., [@B19]) selecting with MOYLS3 medium containing 400 μg/ml of geneticin and 100 μg/ml of spectinomycin, to generate the complemented strain IPAR03. The plasmid was confirmed by PCR amplification of the insert and also by sequencing performed in GATC Biotech, Germany. The complemented mutant strain IPAR03 was grown either in MOYLS3 lactate/sulfite medium or MOYLS4 lactate/sulfate medium (Zane et al., [@B45]; Keller et al., [@B19]) with spectinomycin (100 μg/ml).

Pull-down assay
---------------

For the pull-down assay, IPAR03 was grown in 100 ml of MOYLS4 with spectinomycin at 37°C for about 24 h. Cells were harvested by centrifuging at 2,500 × *g* for 15 min at 4°C, washed with 20 mM Tris--HCl buffer (pH 7.6) + 10% glycerol (v/v), and again centrifuged as before. Cells were then disrupted using BugBuster^®^ Protein Extraction Reagent (Novagen^®^) for 20 min at room temperature and centrifuged at 16,000 × *g* for 20 min at 4°C. The soluble fraction of IPAR03 was loaded in micro-columns containing *Strep*^®^-Tactin resin (IBA GmBH) equilibrated with 50 mM Tris--HCl pH 7.6, 150 mM NaCl, and 10% glycerol (v/v; Buffer W). After five washing steps with Buffer W, the recombinant protein QmoA was eluted with Buffer W containing 2.5 mM desthiobiotin. The elution product was precipitated in acetone and analyzed by SDS-PAGE and Western Blot with *Strep*-Tactin horse radish peroxidase (HRP) conjugate. The co-elution of AprAB with QmoA was detected by Western Blot with Anti-AprAB from *D. desulfuricans*. In a control experiment the same conditions were used with wild-type cells of *D. vulgaris*.

Electron transfer experiments
-----------------------------

The electron transfer between QmoABC and AprAB was tested in spectrophotometer assays inside the anaerobic chamber, using quartz cuvettes equipped with a magnetic stirrer. The first assay was based on AprAB activity, as previously described (Pires et al., [@B33]), following reduction of the menaquinone analog 2,3-dimethyl-1,4-naphthoquinone (DMN) with sulfite (reverse reaction) at 350 nm (at 270 nm there is interference from AMP). DMN (500 μM) reduction was followed in 50 mM Tris--HCl (pH 7.6) with 0.0125% DDM (w/v), 2 mM Na~2~SO~3~, 2 mM AMP, and 0.5 μM of QmoABC after addition of 1.2 μM AprAB. The second assay was based on oxidation of quinol reduced QmoABC by APS (direct reaction). Qmo (0.3 μM) was reduced with different amounts of menadiol (25, 50, 100, 300, 930 μM) in 10 mM Phosphate buffer (pH 7), 0.0125% DDM (w/v). Qmo heme *b* oxidation was followed at 424 nm in the presence of different amounts of APS (30, 60, and 120 μM; Sigma^®^), after addition of 0.1 μM AprAB.

Results
=======

A link between the QmoABC complex and APS reductase was first inferred from the co-localization of their genes in the genomes of several sulfate reducing and SOB. Subsequent deletion of the *qmo* genes in these organisms proved that the Qmo complex is required for the reduction of sulfate in SRP (Zane et al., [@B45]), and the oxidation of sulfite in green sulfur bacteria (Rodriguez et al., [@B35]). However, the fact that no electron transfer could be observed between the two proteins (Pires et al., [@B33]) raised doubts as to whether there is a direct interaction between them, or if other proteins are involved. Recently, a proteomic study of protein--protein interactions in *D. vulgaris* Hildenborough was reported, in which several key proteins were used as baits for affinity purification followed by mass spectrometry (Chhabra et al., [@B6]). The bait proteins included *Strep*-tagged AprA and AprB, and again no evidence for a direct interaction with QmoABC proteins was obtained. However, interactions between redox proteins are notably difficult to observe due to their transient nature, which is required for the fast turnover of electron exchange reactions in energy metabolism (Bashir et al., [@B2]; Martinez-Fabregas et al., [@B24]). In addition, the fact that Qmo is a membrane-associated complex is likely to further hinder proteomic-based studies. These kind of high-throughput approaches, although invaluable from the amount of information that can be obtained, suffer from the use of the same conditions to evaluate many different types of interactions between many different proteins, so a high number of false negative results is likely to occur. In this work we took advantage of the fact that we can purify both QmoABC and AprAB from *D. desulfuricans* ATCC 27774 to perform detailed interaction studies between the two proteins.

Co-immunoprecipitation experiments
----------------------------------

The first approach to evaluate a possible interaction between QmoABC and AprAB complexes was to use co-immunoprecipitation (co-IP). For this we used a Thermo Scientific Pierce^®^ Co-IP kit in which the antibodies are covalently coupled to an amine-reactive resin. Anti-QmoABC or Anti-AprAB specific antibodies were generated using the purified proteins, and immobilized in columns containing the coupling resin. The two antibody-loaded resins were then incubated with the corresponding prey protein (QmoABC or AprAB), washed, and then incubated with the interacting bait partner (AprAB or QmoABC). After several washing steps the retained proteins were eluted and the Co-IP products were separated by SDS-PAGE and blotted to a PVDF membrane. The membranes were treated by Western blot using the antibodies against the bait protein. Two control experiments were run in parallel, where no antibodies were bound to the resin. The Western blot results (Figure [1](#F1){ref-type="fig"}) show that it was possible to co-immunoprecipitate QmoABC and AprAB, using either of the corresponding antibodies, indicating that there is a direct physical interaction between the two proteins. The control experiments reveal some unspecific retention of both proteins, but the strong difference between the experiments and the controls are indicative of co-immunoprecipitation.

![**Western Blot analysis of co-immunoprecipitation experiment**. **(A)** Western Blot with Anti-QmoABC of the elution products of: E -- the Co-IP using immobilized Anti-AprAB antibody; C -- control resin with no antibody. **(B)** Western Blot with Anti-AprAB of the elution products of: E -- the Co-IP using immobilized Anti-QmoABC antibody; C -- control resin with no antibody. M -- Pre-stained molecular mass markers.](fmicb-03-00137-g001){#F1}

Surface plasmon resonance experiments
-------------------------------------

Since an interaction between QmoABC and AprAB was detected we next sought to quantify the kinetics and affinity parameters of this interaction. For this we used SPR, which is a gold standard for studying protein--protein interactions, since it can provide direct quantitative measurements of binding kinetics and affinities, without the need for any labeling methods. Using a CM5 sensor chip we tested covalent immobilization of either QmoABC or AprAB. Considerable loss of immobilized material was observed in the case of QmoABC, likely due to gradual dissociation of subunits, whereas this was not observed with immobilized AprAB. Further studies proceeded using AprAB as the ligand and QmoABC as the analyte. An interaction was again observed between the two proteins, which could be detected even at low concentrations of QmoABC. The dissociation of QmoABC was complete after injection stopped, and did not require special regeneration conditions, which confirms the transient nature of the interaction between the two proteins. The sensorgrams obtained (Figure [2](#F2){ref-type="fig"}A) were used to calculate the binding rate constants, by fitting the results to a 1:1 interaction model with drifting baseline, yielding an association rate constant *k*~a~ = (3.0 ± 0.1) × 10^5^ M^−1^ s^−1^, a dissociation rate constant *k*~d~ = (2.7 ± 0.4) × 10^−2^ s^−1^, and an equilibrium affinity constant *K*~D~ = 90 ± 3 nM. These values reveal a high affinity for the AprAB--QmoABC complex in steady-state conditions, and that the complex dissociation is very fast, as it is to be expected for an electron transfer interaction. To further validate these results we carried out a competition assay in which QmoABC was pre-incubated with two different concentrations of free AprAB in solution before the SPR measurement (Figure [2](#F2){ref-type="fig"}B). This experiment confirmed a reduced interaction between QmoABC and the immobilized AprAB protein, due to the competition of AprAB in solution.

![**Surface plasmon resonance analysis of the interaction between QmoABC (analyte) and immobilized AprAB (ligand)**. **(A)** Sensorgrams obtained from injection of serial dilutions of 62.5, 31.25, 15.6, 7.8, 3.9 nM QmoABC at 15 μl/min flow rate and 25°C. **(B)** Competition experiment where QmoABC (62.5 nM) was mixed with 62.5 (1:1) or 125 nM (1:2) of AprAB before injection.](fmicb-03-00137-g002){#F2}

Cross-linking Far-Western blot
------------------------------

Recently, a modification of the Far-Western protocol to include a cross-linking step was described, which allows for the detection of weak or transient interactions (Sato et al., [@B37]). Since a strong steady-state interaction was detected between QmoABC and AprAB, we used cross-linking Far-Western blot to try to elucidate which subunits are involved in this interaction. In this experiment, the QmoABC subunits were separated in a SDS-PAGE gel and blotted to a PVDF membrane. The membrane was incubated with AprAB, washed, and EDC was then added to promote cross-linking to the retained protein, following which detection was performed by Western blot with Anti-AprAB antibodies (Figure [3](#F3){ref-type="fig"}). This showed a positive signal for the QmoA band and a weaker signal for the QmoC band. A shift in the molecular mass of the Qmo subunits is not expected to occur since they are already fixed in the membrane upon incubation with AprAB. No signals were detected when the experiment was run in the absence of cross-linker. In the reverse experiment where AprAB was run in the gel and the membrane was incubated with QmoABC, followed by cross-linking and detection with Anti-QmoABC antibodies, no signals could be detected. This indicates that in this case the denaturation of the AprAB subunits in SDS-PAGE prevents the interaction with QmoABC.

![**Detection of interacting subunits by cross-linking Far-Western Blot with Anti-AprAB antibodies**. From left to right: M -- Pre-stained molecular mass markers; (1) QmoABC in PVDF membrane was incubated with AprAB (AprAB inc), cross-linked with EDC and detected; (2) positive control with AprAB in PVDF membrane; (3) negative control with QmoABC in PVDF membrane not incubated with AprAB.](fmicb-03-00137-g003){#F3}

Pull-down assay
---------------

Since the QmoA protein is the subunit showing stronger interaction with AprAB, we set up an endogenous pull-down assay using single-epitope tag-affinity purification based on tagged QmoA. No genetic tools are available for the organism *D. desulfuricans* ATCC 27774, but *D. vulgaris* Hildenborough can be genetically manipulated and extensive tools have been developed allowing chromosomal deletion and tagging of specific genes (Chhabra et al., [@B5],[@B6]; Keller et al., [@B19]). A *D. vulgaris* Hildenborough mutant strain lacking the *qmoA* gene (IPAR02) was produced by double homologous recombination, as previously described (Zane et al., [@B45]), and was complemented with plasmid pMOIP05 encoding *qmoA* with a Strep-TEV-FLAG (STF) tag to give strain IPAR03. This strain could grow on lactate/sulfate, in contrast to IPAR02 that only grew on lactate/sulfite, confirming that the complementation was successful. The QmoA protein was detected both in the membrane and in the soluble fraction of strain IPAR03 grown in lactate/sulfate. We took advantage of this fact to perform affinity tag purification of the soluble fraction using Strep-Tactin resin. The desthiobiotin elution fraction was analyzed by SDS-PAGE gel followed by Western blot with antibodies against *D. desulfuricans* AprAB (it was previously confirmed that these antibodies recognized the AprAB protein from *D. vulgaris*). A band for AprA was detected in the Western blot (Figure [4](#F4){ref-type="fig"}), confirming the ability of QmoA to interact and pull-down AprAB from the soluble fraction. In a parallel control experiment with wild-type cells of *D. vulgaris* Hildenborough no band was detected for AprAB.

![**Analysis of Pull-down assay**. *Strep*-Tactin desthiobiotin elution products of soluble fraction from cells expressing STF-tagged QmoA (IPAR03) or wild-type *D. vulgaris* (DvH wt, negative control) analyzed by Western Blot with Anti-AprAB. M -- Pre-stained molecular mass markers.](fmicb-03-00137-g004){#F4}

Electron transfer experiments
-----------------------------

Since it was established that QmoABC can interact directly with AprAB we attempted again to observe electron transfer using anaerobically purified proteins. Previous experiments had been carried out with proteins purified aerobically (Pires et al., [@B33]), which could have suffered some damage to their iron--sulfur centers thus preventing electron transfer. We tested reduction of a menaquinone analog (DMN) with sulfite (reverse reaction), or oxidation of quinol reduced QmoABC by APS (direct reaction; Scheme [1](#F5){ref-type="fig"}). Despite a screening of different conditions, no evidence for electron transfer could be obtained.

![**Schematic representation of the QmoABC--AprAB interaction and the proposed involvement of third partners**. **(A)** In the hypothesis of an electron bifurcation process the putative electron acceptor of QmoB with a high redox potential is represented by a question mark. **(B)** In the hypothesis of an electron confurcating mechanism several possible co-electron donors for the Qmo complex are considered: ferredoxin (Fd), hydrogenase (Hase), formate dehydrogenase (Fdh) or NADH dehydrogenase (Nox). The soluble HdrABC--MvhGAD complex **(C)** and the membrane-bound HdrED **(D)** of methanogens are shown for comparison. The gray dashed arrows represent electron bifurcation in **(A,C)**, or electron confurcation in **(B)**. The gray boxes represent the cytoplasmic membrane with + indicating the periplasm and − the cytoplasm.](fmicb-03-00137-g005){#F5}

Discussion
==========

The AprAB APS reductase from SRP is a heterodimeric iron--sulfur flavoenzyme, which catalyzes the reversible reduction of APS to sulfite and AMP (Lampreia et al., [@B20]). It binds FAD, which is the site of APS reduction, and two \[4Fe--4S\] clusters that serve to transfer electrons from the protein surface to the catalytic site (Fritz et al., [@B10],[@B11]). Its physiological electron donor has not been unequivocally identified, but in many SRP and SOB the *aprAB* genes are part of a *sat--aprBA--qmoABC* gene cluster (Meyer and Kuever, [@B25],[@B26]; Frigaard and Dahl, [@B8]; Gregersen et al., [@B12]; Pereira et al., [@B32]; *sat* codes for the sulfate adenylyltransferase), which together with other indirect evidence (Pires et al., [@B33]; Haveman et al., [@B13]) led to the general conviction that QmoABC is the missing electron donor to AprAB, linking the quinone pool to sulfate reduction. The essential role of QmoABC in sulfate reduction has been recently established (Zane et al., [@B45]), but a direct connection between the two proteins has not been reported and direct electron transfer could not be observed (Pires et al., [@B33]). In some SOB lineages the *qmoABC* genes are absent and instead an *aprM* gene coding for a membrane protein is present (Hipp et al., [@B15]; Meyer and Kuever, [@B25]; Frigaard and Dahl, [@B8]), suggesting that AprM can replace QmoABC in electron exchange between AprAB and the quinone pool. Homology modeling of AprAB from the different SOB lineages highlighted differences in the AprB structure that correlate with the presence of either the *qmo* or *aprM* genes. This points to adaptation of the electron transfer protein AprB as a result of docking to either Qmo or AprM proteins (Meyer and Kuever, [@B27]), and further substantiates a direct interaction.

In this work we report the first evidence that in SRP the QmoABC complex interacts directly with the APS reductase. This interaction could be detected by co-IP, and SPR showed that the two proteins are involved in a transient interaction that has a strong affinity (*K*~D~ = 90 ± 4 nM) in equilibrium conditions, and which has a fast dissociation rate. This property allowed the cross-linking of two proteins and detection by Far-Western blot, which revealed that the QmoA subunit, and to a less extent QmoC, is involved in the interaction. The reverse experiment gave no results, but in the case of AprAB it is known that AprA is the catalytic subunit and AprB the electron transfer subunit (Fritz et al., [@B10],[@B11]), so that interaction with the electron donor should involve AprB. Expression of a tagged version of QmoA in *D. vulgaris* Hildenborough, followed by affinity purification allowed the detection of co-eluting AprAB, further confirming a specific direct interaction between the two proteins in a physiological setting.

However, reduction of APS with a menaquinol analog in the presence of QmoABC and AprAB could not be detected. The QmoABC subunits bind two hemes *b*, two FAD groups and several iron--sulfur centers, and are homologous to subunits of soluble (HdrABC) and membrane-bound (HdrED) heterodisulfide reductases from methanogens (Scheme [1](#F5){ref-type="fig"}; Pires et al., [@B33]; Thauer et al., [@B43]). QmoA and QmoB are both soluble iron--sulfur flavoproteins homologous to HdrA, the flavin-containing subunit of soluble HDRs. The function of HdrA has not been completely established, but it has been proposed to be involved in flavin-based electron bifurcation carried out by a complex between HdrABC and the F~420~-non-reducing MvhADG hydrogenase (Scheme [1](#F5){ref-type="fig"}C), which allows the coupling between the exergonic reduction of the CoM-S-S-CoB heterodisulfide by H~2~ to the endergonic reduction of ferredoxin by H~2~ (Thauer et al., [@B43]; Kaster et al., [@B17]). This bifurcation process is believed to involve the HdrA FAD cofactor, which transfers one electron to the heterodisulfide through HdrBC and another electron to ferredoxin. Such process may also occur with formate instead of H~2~, with a formate dehydrogenase replacing the Mvh hydrogenase (Costa et al., [@B7]). QmoB includes also a domain similar to MvhD, the \[2Fe--2S\] subunit of the Mvh hydrogenase that is responsible for electron transfer to HdrABC (Scheme [1](#F5){ref-type="fig"}C; Stojanowic et al., [@B42]). QmoC is a fusion protein that contains a cytochrome *b* transmembrane domain related to HdrE (Scheme [1](#F5){ref-type="fig"}D) and a hydrophilic iron--sulfur domain related to electron transfer subunit HdrC. Thus, QmoC fuses in a single protein the two subunits that in many trimeric respiratory oxidoreductases (composed of membrane subunit, electron transfer subunit, and catalytic subunit) are responsible for electron exchange with the quinone pool and electron transfer to the catalytic subunit (Rothery et al., [@B36]; Simon et al., [@B40]). This leaves two subunits, QmoA and QmoB, with an unknown function and which will likely interact with other physiological partners. QmoA is shown here to interact with AprAB, but the function of QmoB remains enigmatic. Its similarity to HdrA and MvhD suggests the involvement of a third physiological partner for the Qmo complex. We must also consider that menaquinol (*E*^0^′ −75 mV) cannot serve as sole electron donor to reduce APS $\left( {E^{0^{\prime}}\text{APS/SO}_{3}^{2 -} = - 60\text{mV}} \right)$ due to the small difference in redox potentials, and to the fact that the membrane potential (∼150 mV) has to be overcome when transferring electrons from the quinone binding site in QmoC (likely situated toward the periplasmic side of the membrane) to AprAB in the cytoplasm. Thus, the reduction of APS by menaquinol has to be driven by coupling it to a second more favorable reaction. The idea that an electron bifurcation or confurcation mechanism, originally proposed by Buckel and coworkers (Herrmann et al., [@B14]), could be operating in the reduction of APS then appears as a very attractive and plausible hypothesis. Two possibilities can be envisioned: in the first one (Scheme [1](#F5){ref-type="fig"}A) the QmoB subunit reduced by menaquinol could bifurcate electrons to QmoA/AprAB and to a second electron acceptor with a high redox potential. The energetically favorable reduction of such electron acceptor by menaquinol could drive the unfavorable reduction of APS by menaquinol. The only problem with this hypothesis is that we cannot identify a candidate in SRB with a high enough reduction potential to drive this reaction.

The second possibility, that we favor, is to consider a reverse electron bifurcation mechanism, which has been referred to as electron confurcation. In such a process menaquinol and a cytoplasmic reductant of low redox potential could both serve as electron donors to the Qmo complex, which would confurcate electrons to the APS reductase (Scheme [1](#F5){ref-type="fig"}B). The favorable reduction of APS by this low potential electron donor would drive the unfavorable reduction of APS by menaquinol. The process of bifurcation/confurcation requires the presence of a two-electron center, such as a flavin, as the coupling site. In Qmo there are two FAD cofactors that can perform this process. According to the idea of crossed potentials at the flavin proposed by Nitschke and Russell ([@B30]), the reduction of FAD at QmoA or QmoB by the low potential electron donor could generate a "hot" flavosemiquinone with a high redox potential that would then be a favorable electron acceptor for a second electron coming from menaquinol, and in practice "pulling" this electron from the quinone. Electron confurcation has been reported in the reduction of NADP^+^ with both reduced ferredoxin and NADH by *Clostridium kluyveri* NfnAB (Wang et al., [@B44]), and also in a multimeric soluble \[FeFe\] hydrogenase from *Thermotoga maritima*, which uses both NADH and reduced ferredoxin to produce H~2~ (Schut and Adams, [@B38]). This process has also been implicated in the energy metabolism of syntrophic organisms (Müller et al., [@B28]; Sieber et al., [@B39]).

Several coupling partners for Qmo can be considered in the confurcation hypothesis. The first is a hydrogenase or a formate dehydrogenase by analogy to what happens with HdrABC of methanogens (Costa et al., [@B7]; Kaster et al., [@B17]). An analysis of SRP genomes showed that a cytoplasmic version of either one of the two enzymes is always present (Pereira et al., [@B32]), except in *C. maquilingensis* where the *qmoABC* genes are also absent. In several organisms an MvhADG homolog is present, which in the archeal and in some bacterial organisms is part of an *mvhADG--hdrABC* gene cluster, suggesting this was acquired by lateral gene transfer from methanogenic organisms. In other bacteria the *mvhADG* genes are isolated, which may indicate subsequent loss of the *hdrABC* genes. In *Desulfovibrio* organisms no *mvhADG* genes are present, but genes coding for a membrane-associated hydrogenase (Ech or Coo) or a soluble \[FeFe\] hydrogenase are detected. The second possible partner for QmoB is a ferredoxin, also by analogy to HdrA. Ferredoxins are present in the genomes of all SRP, often in multiple copies (Pereira et al., [@B32]). Several proteins in SRP are known to reduce ferredoxin, including hydrogenases and formate dehydrogenases, pyruvate:ferredoxin oxidoreductase and the Rnf complex, which is also present in several *Desulfovibrio* spp. (Pereira et al., [@B32]). Finally, a third possible partner of QmoB is the mononuclear NADH oxidoreductase, Nox, which has been reported to reduce AprAB (Chen et al., [@B4]). Nox homologs (DVU3212 in *D. vulgaris* Hildenborough) are also present in the 25 genomes of SRP analyzed, except *Thermodesulfovibrio yellowstonii*. Recently, a study of protein--protein interactions failed to detect a link between Nox and energy metabolism proteins (Chhabra et al., [@B6]), but such a negative result is not entirely conclusive due to the possibility of transient interactions not being detected in the conditions used. In these hypotheses H~2~ (*E*^0^′ −414 mV), formate (*E*^0^′ −430 mV), NADH (*E*^0^′ −320 mV), or ferredoxin (*E*^0^′ ∼−400 mV), would all be favorable reductants for APS $\left( {E^{0^{\prime}}\text{APS/SO}_{3}^{2 -} = - 60\text{mV}} \right)$. It is conceivable that more than one of these compounds may be used depending on the metabolic conditions, as observed for HdrABC (Costa et al., [@B7]), which could explain why no genes for interacting partners are co-localized with the *sat--aprBA--qmoABC* gene cluster. Any of these reductants could serve as a sole electron donor for the reduction of APS on its own, but in such situation the cells would get no energy benefit from this step. Coupling of APS reduction with oxidation of the menaquinone pool allows for energy conservation, considering that the oxidation of menaquinol by QmoC occurs at the periplasmic side of the membrane, with release of protons to the periplasm. In conclusion, the confurcation mechanism proposed here effectively allows the coupling of sulfate reduction with chemiosmotic energy conservation, a process long known to occur in SRP, but for which the molecular basis has been hard to identify. Clearly, further experiments will be required to test this hypothesis.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This work was supported (for Ana Raquel Ramos and Inês A. Cardoso Pereira) by research grants PTDC/QUI-BIQ/100591/2008 funded by Fundação para a Ciência e Tecnologia and FEDER program, and by grant PEst-OE/EQB/LA0004/2011; and (for Judy D. Wall and Kimberly L. Keller) by ENIGMA -- Ecosystems and Networks Integrated with Genes and Molecular Assemblies supported by the Office of Science, Office of Biological, and Environmental Research, of the U.S. Department of Energy (DOE) under Contract No. DE-AC02-05CH11231 and by DOE grant DE-FG02-08ER64691. A. R. Ramos was supported by FCT Ph.D. fellowship SFRH/BD/60500/2009. We thank Manuela M. Pereira, Wolfgang Nitschke, and Wolfgang Buckel for helpful discussions.

[^1]: Edited by: Niels-Ulrik Frigaard, University of Copenhagen, Denmark

[^2]: Reviewed by: Ulrike Kappler, University of Queensland, Australia; Ben Berks, University of Oxford, UK

[^3]: This article was submitted to Frontiers in Microbial Physiology and Metabolism, a specialty of Frontiers in Microbiology.
